The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated•Originally published 7 May 2026•Updated 8 May 2026•

1 min read

Mixed Q1 Results for Healthcare and Tech Firms as Losses Widen

Key Facts

1Apyx Medical reported a quarterly loss of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.11.

2Akebia Therapeutics reported a quarterly loss of $0.03 per share, missing the Zacks Consensus Estimate of a loss of $0.01.

Q1 financial results for several small and mid-cap firms showed significant divergence, with a general trend toward wider-than-expected losses. In the healthcare sector, Apyx Medical and Treace Medical Concepts outperformed estimates, reporting losses of $0.05 and $0.28 per share, respectively. Conversely, Akebia Therapeutics and 1stdibs.com missed projections with losses of $0.03 and $0.06 per share. TeraWulf Inc. faced substantial pressure, reporting a loss of $0.44 per share, significantly missing the $0.16 consensus estimate. Additionally, Sylvamo Corporation posted a loss of $0.53 per share, a sharp decline from its prior-year profit and worse than analyst expectations. These results highlight mounting operational challenges in a volatile economic environment, increasing pressure on these firms to demonstrate a path to profitability.

26 days ago

Version History

3 additional sources confirmed this story

Version 126 days ago

What changed: The story was expanded to include Q1 earnings results for TMCI, WULF, DIBS, and SLVM, showing a trend of wider-than-expected losses for most of these firms.